Analyze Diet

Equine Bone Marrow Aspirate Concentrate.

Abstract: Bone marrow concentrate is generated by centrifugation of bone marrow aspirate. It contains mesenchymal stromal cells, anabolic chemokines/cytokines, and supraphysiological concentrations of interleukin-1 receptor antagonist protein (IL-1RA). It is an effective treatment for osteoarthritis or desmitis, or as an adjunct in surgery to enhance bone or cartilage repair.
Publication Date: 2023-07-11 PubMed ID: 37442728DOI: 10.1016/j.cveq.2023.05.002Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Bone marrow concentrate is an advancement in biological medicine which harnesses the body’s natural healing elements for treatment. It is developed from bone marrow aspirate using centrifugation and has shown promise in the fields of osteoarthritis, desmitis, and orthopedic surgery to boost bone and cartilage repair.

Extracting Bone Marrow Concentrate

Bone marrow concentrate (BMC) is produced from bone marrow aspirates – a process which requires the extraction of marrow from a patient’s bone. The marrow is extracted with a procedure known as aspiration, and this marrow – containing potent substances such as mesenchymal stromal cells, anabolic chemokines/cytokines – is then subjected to a process called centrifugation. This technique spins the bone marrow aspirate at high speed to separate its diverse components, subsequently producing BMC.

  • Mesenchymal stromal cells – These are fundamentally responsible for the healing and regenerative properties attributed to BMC. They are capable of differentiating into various cell types including bone cells, cartilage cells, and muscle cells, which makes them valuable for therapeutic applications.
  • Anabolic chemokines/cytokines – These are signaling proteins that indulge in cellular interactions as well as in the modulation of cell behavior, thereby potentially assisting in the repair of body tissues.
  • Interleukin-1 receptor antagonist protein (IL-1RA) – This protein inhibits the activities of interleukin-1, and is present in higher concentrations in BMC. Since the IL-1RA curbs inflammation and cartilage degeneration, its increased proportions in BMC can be utilized in treatments.

Application of Bone Marrow Concentrate

BMC showcases enormous potential in the treatment of different forms of arthritis and injuries that traditionally necessitated surgery or which did not respond to conventional treatments.

  • Arthritis and desmitis treatment – There has been ample research which suggests that BMC helps recover patients suffering from osteoarthritis, mainly by regenerating the damaged cartilage. Similarly, inflammation of ligaments or tendons, known as desmitis, can respond positively to BMC treatment due to its natural healing capabilities.
  • Surgery adjunct – The administration of BMC can supplement surgical procedures by enhancing healing and recovery. Its role in promoting bone and cartilage repair post-surgery can reduce convalescence periods and improve surgical outcomes.

Cite This Article

APA
Fortier LA. (2023). Equine Bone Marrow Aspirate Concentrate. Vet Clin North Am Equine Pract. https://doi.org/10.1016/j.cveq.2023.05.002

Publication

ISSN: 1558-4224
NlmUniqueID: 8511904
Country: United States
Language: English

Researcher Affiliations

Fortier, Lisa A
  • Clinical Sciences, Cornell University College of Veterinary Medicine, Ithaca, NY, USA. Electronic address: lfortier@avma.org.

Citations

This article has been cited 5 times.
  1. Sabzpoosh M, Hoveizi E, Gooraninejad S. Isolation and differentiation of endometrial mesenchymal stem cells from Arabian mares. In Vitro Cell Dev Biol Anim 2025 Dec;61(10):1187-1192.
    doi: 10.1007/s11626-025-01103-5pubmed: 41288937google scholar: lookup
  2. Najeb M, Samy A, Rizk A, Mosbah E, Karrouf G. Regenerative biologics modulating inflammation and promoting tenogenesis in equine superficial digital flexor tendonitis: from molecular pathways to clinical translation. Ir Vet J 2025 Sep 17;78(1):21.
    doi: 10.1186/s13620-025-00309-zpubmed: 40963139google scholar: lookup
  3. Marcellin-Little DJ, Hulse DA, Huntingford JL, Grubb T, Brunke MW, Markley AP, Frank B. A proposed framework for practical multimodal management of osteoarthritis in growing dogs. Front Vet Sci 2025;12:1565922.
    doi: 10.3389/fvets.2025.1565922pubmed: 40357193google scholar: lookup
  4. Guerra-Gomes M, Ferreira-Baptista C, Barros J, Alves-Pimenta S, Gomes P, Colaço B. Exploring the Potential of Non-Cellular Orthobiologic Products in Regenerative Therapies for Stifle Joint Diseases in Companion Animals. Animals (Basel) 2025 Feb 18;15(4).
    doi: 10.3390/ani15040589pubmed: 40003071google scholar: lookup
  5. Berni P, Andreoli V, Conti V, Ramoni R, Basini G, Scattini G, Pascucci L, Pellegrini M, Del Bue M, Squassino GP, Paino F, Pessina A, Alessandri G, Pirazzoli P, Bosetto A, Grolli S. Evaluation of a Novel Mechanical Device for the Production of Microfragmented Adipose Tissue for Veterinary Regenerative Medicine: A Proof-of-Concept. Int J Mol Sci 2024 Nov 4;25(21).
    doi: 10.3390/ijms252111854pubmed: 39519405google scholar: lookup